X2H13R9Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9
- Billable / Specific Code
X2H13R9 is a billable ICD-10-PCS procedure code for Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to 39 MS-DRGs. The root operation Insertion involves putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | 2 | Cardiovascular System |
| 3 | Operation | H | Insertion |
| 4 | BodyPart | 1 | Superior Vena Cava |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | R | Intraluminal Device, Bioprosthetic Valve |
| 7 | Qualifier | 9 | New Technology Group 9 |
Code History
- 02HV3DZ — Insertion of Intralum Dev into Sup Vena Cava, Perc Approach
Similar Procedure Codes
Questions About X2H13R9
Is X2H13R9 a billable code?
Yes. X2H13R9 is a complete seven-character ICD-10-PCS code, specific enough to report Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in X2H13R9 mean?
X2H13R9 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character 2 is the Body System (Cardiovascular System); the 3rd character H is the Operation (Insertion); the 4th character 1 is the BodyPart (Superior Vena Cava); the 5th character 3 is the Approach (Percutaneous); the 6th character R is the Device/Substance/Technology (Intraluminal Device, Bioprosthetic Valve); the 7th character 9 is the Qualifier (New Technology Group 9).
What MS-DRG does X2H13R9 group to?
On an inpatient stay, Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9 maps to MS-DRGs 040, 041, 042, 166, 167, 168, 252, 253, 254, 356, 357, 358, 423, 424, 425, 515, 516, 517, 628, 629, 630, 673, 674, 675, 715, 716, 717, 718, 749, 750, 802, 803, 804, 907, 908, 909, 957, 958, 959, with relative weights from 1.3127 to 7.6199. The MS-DRG sets the fixed Medicare payment for the stay.
